Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $GTHP vs $SINT | Chartloom

Compare

$GTHP vs $SINT

Guided Therapeutics Inc · SINTX Technologies Inc

GTHP

Guided Therapeutics Inc

SINT

SINTX Technologies Inc

Compare $GTHP vs $SINT

Comparing Guided Therapeutics Inc and SINTX Technologies Inc

GTHPGuided Therapeutics Inc

SINTSINTX Technologies Inc

GTHPGuided Therapeutics Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

450.8%

YTD performance

-64.8%

52W performance

-17.4%

FCF yield

-8.2%

SINTSINTX Technologies Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.87x

Rev growth (TTM)

-28.5%

YTD performance

-45.2%

52W performance

-50.0%

FCF yield

-80.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTHP

SINT

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

SINT

SINTX Technologies Inc

Market Cap

GTHP$18M

SINT$13M

Enterprise Value

GTHP$20M

SINT$9M

Price

GTHP$0.19

SINT$2.07

P/E Ratio

GTHPN/A

SINTN/A

P/S Ratio

GTHP28.22x

SINT9.65x

EV/Sales

GTHP31.44x

SINT7.03x

EV/EBITDA

GTHP0.00x

SINT0.00x

P/B Ratio

GTHP35.27x

SINT2.91x

P/FCF Ratio

GTHPN/A

SINTN/A

EV/FCF

GTHP-13.57x

SINT-0.90x

PEG Ratio

GTHPN/A

SINTN/A

Forward P/E (NTM)

GTHPN/A

SINTN/A

Forward P/S (NTM)

GTHPN/A

SINT2.87x

Revenue (TTM)

GTHP$650K

SINT$1M

Revenue Growth (YoY)

GTHP450.8%

SINT-28.5%

Forward Rev Growth

GTHP0.0%

SINT135.2%

Gross Margin (TTM)

GTHP75.8%

SINT52.9%

Operating Margin (TTM)

GTHP0.0%

SINT0.0%

EBITDA Margin (TTM)

GTHP-336.2%

SINT-861.3%

Net Margin (TTM)

GTHP-560.6%

SINT-1423.0%

FCF Margin (TTM)

GTHP-231.7%

SINT-777.1%

Net Income (TTM)

GTHP$-4M

SINT$-19M

FCF (TTM)

GTHP$-2M

SINT$-10M

EPS (TTM)

GTHP-$0.04

SINT-$3.90

ROE (TTM)

GTHP-47148.0%

SINT-35444.0%

ROA (TTM)

GTHP-24393.0%

SINT-11537.0%

ROIC (TTM)

GTHP-37126.0%

SINT-34697.0%

Cash

GTHP$12K

SINT$4M

Debt

GTHP$2M

SINT$102K

Net Cash/Debt

GTHP$-2M

SINT$3M

Current Ratio (TTM)

GTHP0.09x

SINT2.36x

Quick Ratio (TTM)

GTHP0.00x

SINT1.32x

Debt/Equity (TTM)

GTHP0.60x

SINT0.02x

Debt/Assets (TTM)

GTHP0.0%

SINT0.0%

Interest Coverage (TTM)

GTHPN/A

SINTN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

SINT0.00x

Beta

GTHP0.68

SINT0.58

52W Performance

GTHP-17.4%

SINT-50.0%

YTD Performance

GTHP-64.8%

SINT-45.2%

% from 52W High

GTHP-64.8%

SINT-54.0%

% from 52W Low

GTHP58.3%

SINT47.9%

Asset Turnover (TTM)

GTHP0.73x

SINT0.14x

FCF Yield (TTM)

GTHP-8.2%

SINT-80.5%

Earnings Yield (TTM)

GTHP-19.9%

SINT-147.5%

Dividend Yield (TTM)

GTHPN/A

SINTN/A

Rule of 40

GTHP219.2

SINT-805.7

EV/GP/RG

GTHPN/A

SINT0.06

Ticker research

View GTHP research View SINT research

Metric	GTHP Guided Therapeutics Inc	SINT SINTX Technologies Inc
Market & Valuation
Market Cap	$18M	$13M
Enterprise Value	$20M	$9M
Price	$0.19	$2.07
P/E Ratio	N/A	N/A
P/S Ratio	28.22x	9.65x
EV/Sales	31.44x	7.03x
EV/EBITDA	0.00x	0.00x
P/B Ratio	35.27x	2.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.57x	-0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.87x
Revenue & Growth
Revenue (TTM)	$650K	$1M
Revenue Growth (YoY)	450.8%	-28.5%
Forward Rev Growth	0.0%	135.2%
Profitability
Gross Margin (TTM)	75.8%	52.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-861.3%
Net Margin (TTM)	-560.6%	-1423.0%
FCF Margin (TTM)	-231.7%	-777.1%
Net Income (TTM)	$-4M	$-19M
FCF (TTM)	$-2M	$-10M
EPS (TTM)	-$0.04	-$3.90
ROE (TTM)	-47148.0%	-35444.0%
ROA (TTM)	-24393.0%	-11537.0%
ROIC (TTM)	-37126.0%	-34697.0%
Financial Health
Cash	$12K	$4M
Debt	$2M	$102K
Net Cash/Debt	$-2M	$3M
Current Ratio (TTM)	0.09x	2.36x
Quick Ratio (TTM)	0.00x	1.32x
Debt/Equity (TTM)	0.60x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	0.58
52W Performance	-17.4%	-50.0%
YTD Performance	-64.8%	-45.2%
% from 52W High	-64.8%	-54.0%
% from 52W Low	58.3%	47.9%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.14x
FCF Yield (TTM)	-8.2%	-80.5%
Earnings Yield (TTM)	-19.9%	-147.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-805.7
EV/GP/RG	N/A	0.06
Ticker research	View GTHP research	View SINT research

Valuation

P/S Ratio

SINT

9.65x

GTHP

28.22x

EV/FCF

GTHP

-13.57x

SINT

-0.90x

Growth & revenue

Revenue Growth TTM

GTHP

450.8%

SINT

-28.5%

Forward Revenue Growth

SINT

135.2%

GTHP

0.0%

Profitability & performance

Gross Margin

GTHP

75.8%

SINT

52.9%

ROE

SINT

-35444.0%

GTHP

-47148.0%

FCF Yield %

GTHP

-8.2%

SINT

-80.5%

52-Week Performance

GTHP

-17.4%

SINT

-50.0%

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

SINT

SINTX Technologies Inc

Market Cap

GTHP$18M

SINT$13M

Enterprise Value

GTHP$20M

SINT$9M

Price

GTHP$0.19

SINT$2.07

P/E Ratio

GTHPN/A

SINTN/A

P/S Ratio

GTHP28.22x

SINT9.65x

EV/Sales

GTHP31.44x

SINT7.03x

EV/EBITDA

GTHP0.00x

SINT0.00x

P/B Ratio

GTHP35.27x

SINT2.91x

P/FCF Ratio

GTHPN/A

SINTN/A

EV/FCF

GTHP-13.57x

SINT-0.90x

PEG Ratio

GTHPN/A

SINTN/A

Forward P/E (NTM)

GTHPN/A

SINTN/A

Forward P/S (NTM)

GTHPN/A

SINT2.87x

Revenue (TTM)

GTHP$650K

SINT$1M

Revenue Growth (YoY)

GTHP450.8%

SINT-28.5%

Forward Rev Growth

GTHP0.0%

SINT135.2%

Gross Margin (TTM)

GTHP75.8%

SINT52.9%

Operating Margin (TTM)

GTHP0.0%

SINT0.0%

EBITDA Margin (TTM)

GTHP-336.2%

SINT-861.3%

Net Margin (TTM)

GTHP-560.6%

SINT-1423.0%

FCF Margin (TTM)

GTHP-231.7%

SINT-777.1%

Net Income (TTM)

GTHP$-4M

SINT$-19M

FCF (TTM)

GTHP$-2M

SINT$-10M

EPS (TTM)

GTHP-$0.04

SINT-$3.90

ROE (TTM)

GTHP-47148.0%

SINT-35444.0%

ROA (TTM)

GTHP-24393.0%

SINT-11537.0%

ROIC (TTM)

GTHP-37126.0%

SINT-34697.0%

Cash

GTHP$12K

SINT$4M

Debt

GTHP$2M

SINT$102K

Net Cash/Debt

GTHP$-2M

SINT$3M

Current Ratio (TTM)

GTHP0.09x

SINT2.36x

Quick Ratio (TTM)

GTHP0.00x

SINT1.32x

Debt/Equity (TTM)

GTHP0.60x

SINT0.02x

Debt/Assets (TTM)

GTHP0.0%

SINT0.0%

Interest Coverage (TTM)

GTHPN/A

SINTN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

SINT0.00x

Beta

GTHP0.68

SINT0.58

52W Performance

GTHP-17.4%

SINT-50.0%

YTD Performance

GTHP-64.8%

SINT-45.2%

% from 52W High

GTHP-64.8%

SINT-54.0%

% from 52W Low

GTHP58.3%

SINT47.9%

Asset Turnover (TTM)

GTHP0.73x

SINT0.14x

FCF Yield (TTM)

GTHP-8.2%

SINT-80.5%

Earnings Yield (TTM)

GTHP-19.9%

SINT-147.5%

Dividend Yield (TTM)

GTHPN/A

SINTN/A

Rule of 40

GTHP219.2

SINT-805.7

EV/GP/RG

GTHPN/A

SINT0.06

Ticker research

View GTHP research View SINT research

Metric	GTHP Guided Therapeutics Inc	SINT SINTX Technologies Inc
Market & Valuation
Market Cap	$18M	$13M
Enterprise Value	$20M	$9M
Price	$0.19	$2.07
P/E Ratio	N/A	N/A
P/S Ratio	28.22x	9.65x
EV/Sales	31.44x	7.03x
EV/EBITDA	0.00x	0.00x
P/B Ratio	35.27x	2.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.57x	-0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.87x
Revenue & Growth
Revenue (TTM)	$650K	$1M
Revenue Growth (YoY)	450.8%	-28.5%
Forward Rev Growth	0.0%	135.2%
Profitability
Gross Margin (TTM)	75.8%	52.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-861.3%
Net Margin (TTM)	-560.6%	-1423.0%
FCF Margin (TTM)	-231.7%	-777.1%
Net Income (TTM)	$-4M	$-19M
FCF (TTM)	$-2M	$-10M
EPS (TTM)	-$0.04	-$3.90
ROE (TTM)	-47148.0%	-35444.0%
ROA (TTM)	-24393.0%	-11537.0%
ROIC (TTM)	-37126.0%	-34697.0%
Financial Health
Cash	$12K	$4M
Debt	$2M	$102K
Net Cash/Debt	$-2M	$3M
Current Ratio (TTM)	0.09x	2.36x
Quick Ratio (TTM)	0.00x	1.32x
Debt/Equity (TTM)	0.60x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	0.58
52W Performance	-17.4%	-50.0%
YTD Performance	-64.8%	-45.2%
% from 52W High	-64.8%	-54.0%
% from 52W Low	58.3%	47.9%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.14x
FCF Yield (TTM)	-8.2%	-80.5%
Earnings Yield (TTM)	-19.9%	-147.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-805.7
EV/GP/RG	N/A	0.06
Ticker research	View GTHP research	View SINT research